LSI Real-Time Flow and Perfusion Imaging Project
Grant
Overview
abstract
-
ABSTRACT The purpose of this amendment is to continue sponsorship of Mr. Jin through the end of the current SRA year, in June of 2019. Mr Jin has shifted his PhD focus from his University in China to continue this work on near-infrared fluorescence imaging combined with the research and development aspects of the novel imaging technology invented by Drs. Ferguson, Chen and Hu here at ECU. RFPi, LLC has exclusively licensed this technology for commercial development, and this partnership with ECU facilitates the cost-effective refinement of this platform technology?s expansion into new commercial applications. The objective of this extension is to continue to capitalize on the remarkable progress with this ECU technology thus far. RFPi, Inc., has just received FDA approval for the initial clinical application of this technology, called iCertainty. This has been based in part on animal studies (n=21) performed in the Warren Life Sciences Building on the 2nd Floor. The support from the Department of Comparative Medicine has been invaluable, and this SRA arrangement has enabled this cost-effective and highly productive collaboration, and these experiments will continue. The other developmental work on this project will continue to be performed in the Department of Physics Laboratories in the Howell Science Complex. As per the SRA, the prototype of this combined device was built in the Multi-Spectral Physiologic Visualization (MSPV) Optics Lab in the Warren Life Sciences Building and the Dept. of Physics Machine shop, and all modifications to the hardware continue to be performed in these facilities. IP issues surrounding this new technology combination are secured through the existing patents related to MSPV and the additional patents filed/to be filed on this new technology combination.
date/time interval
awarded by